{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:28:27Z","timestamp":1788917307952,"version":"build-2803163510"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"DOI":"10.7759\/cureus.102964","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:31:32Z","timestamp":1770219092000},"source":"Crossref","is-referenced-by-count":2,"title":["When Type 2 Diabetes Isn\u2019t Type 2: Latent Autoimmune Diabetes in a Lean, Highly Physically Active Adult"],"prefix":"10.7759","author":[{"given":"Saraswathi","family":"Saiprasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayana","family":"Swamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti R","year":"2020","unstructured":"Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes. 2020, 69:2037-47. 10.2337\/dbi20-0017","journal-title":"Diabetes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.295970","article-title":"A clinical screening tool identifies autoimmune diabetes in adults","volume":"29","author":"Fourlanos S","year":"2006","unstructured":"Fourlanos S, Perry C, Stein MS, Stankovich J, Harrison LC, Colman PG. A clinical screening tool identifies autoimmune diabetes in adults. Diabetes Care. 2006, 29:970-5. 10.2337\/diacare.295970","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2018.0190","article-title":"Latent autoimmune diabetes in adults: a review on clinical implications and management","volume":"42","author":"Pieralice S","year":"2018","unstructured":"Pieralice S, Pozzilli P. Latent autoimmune diabetes in adults: a review on clinical implications and management. Diabetes Metab J. 2018, 42:451-64. 10.4093\/dmj.2018.0190","journal-title":"Diabetes Metab J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0931","article-title":"Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7","volume":"36","author":"Hawa MI","year":"2013","unstructured":"Hawa MI, Kolb H, Schloot N, et al.. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7. Diabetes Care. 2013, 36:908-13. 10.2337\/dc12-0931","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-0685","article-title":"Safety and efficacy of sustained automated insulin delivery compared with sensor and pump therapy in adults with type 1 diabetes at high risk for hypoglycemia: a randomized controlled trial","volume":"46","author":"Renard E","year":"2023","unstructured":"Renard E, Joubert M, Villard O, et al.. Safety and efficacy of sustained automated insulin delivery compared with sensor and pump therapy in adults with type 1 diabetes at high risk for hypoglycemia: a randomized controlled trial. Diabetes Care. 2023, 46:2180-7. 10.2337\/dc23-0685","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/15209156251395014","article-title":"Real-world HbA1c following initiation of the Omnipod 5 automated insulin delivery system","author":"Levy CJ","year":"2025","unstructured":"Levy CJ, Carlow D, Swift D, et al.. Real-world HbA1c following initiation of the Omnipod 5 automated insulin delivery system. Diabetes Technol Ther. 2025, 10.1177\/15209156251395014","journal-title":"Diabetes Technol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14501","article-title":"Low C-peptide together with a high glutamic acid decarboxylase autoantibody level predicts progression to insulin dependence in latent autoimmune diabetes in adults: the HUNT study","volume":"23","author":"S\u00f8rgjerd EP","year":"2021","unstructured":"S\u00f8rgjerd EP, \u00c5svold BO, Grill V. Low C-peptide together with a high glutamic acid decarboxylase autoantibody level predicts progression to insulin dependence in latent autoimmune diabetes in adults: the HUNT study. Diabetes Obes Metab. 2021, 23:2539-50. 10.1111\/dom.14501","journal-title":"Diabetes Obes Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-1550","article-title":"Efficacy and safety of a tubeless AID system compared with pump therapy with CGM in the treatment of type 1 diabetes in adults with suboptimal glycemia: a randomized, parallel-group clinical trial","volume":"47","author":"Renard E","year":"2024","unstructured":"Renard E, Weinstock RS, Aleppo G, et al.. Efficacy and safety of a tubeless AID system compared with pump therapy with CGM in the treatment of type 1 diabetes in adults with suboptimal glycemia: a randomized, parallel-group clinical trial. Diabetes Care. 2024, 47:2248-57. 10.2337\/dc24-1550","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30003-6","article-title":"Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)","volume":"8","author":"Maddaloni E","year":"2020","unstructured":"Maddaloni E, Coleman RL, Agbaje O, Buzzetti R, Holman RR. Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86). Lancet Diabetes Endocrinol. 2020, 8:206-15. 10.1016\/S2213-8587(20)30003-6","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454026-when-type-2-diabetes-isnt-type-2-latent-autoimmune-diabetes-in-a-lean-highly-physically-active-adult","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:31:33Z","timestamp":1770219093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454026-when-type-2-diabetes-isnt-type-2-latent-autoimmune-diabetes-in-a-lean-highly-physically-active-adult"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.102964","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}